Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 628

1.

The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy.

Venkateswaran RV, Dronavalli V, Lambert PA, Steeds RP, Wilson IC, Thompson RD, Mascaro JG, Bonser RS.

Transplantation. 2009 Aug 27;88(4):582-8. doi: 10.1097/TP.0b013e3181b11e5d.

PMID:
19696643
2.

The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial.

Venkateswaran RV, Steeds RP, Quinn DW, Nightingale P, Wilson IC, Mascaro JG, Thompson RD, Townend JN, Bonser RS.

Eur Heart J. 2009 Jul;30(14):1771-80. doi: 10.1093/eurheartj/ehp086. Epub 2009 Mar 26.

3.

Echocardiography in the potential heart donor.

Venkateswaran RV, Townend JN, Wilson IC, Mascaro JG, Bonser RS, Steeds RP.

Transplantation. 2010 Apr 15;89(7):894-901. doi: 10.1097/TP.0b013e3181cfe8e9.

PMID:
20075789
4.

Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation.

Wagner FD, Jonitz B, Potapov EV, Qedra N, Wegscheider K, Abraham K, Ivanitskaia EA, Loebe M, Hetzer R.

Circulation. 2001 Sep 18;104(12 Suppl 1):I192-6.

5.

Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis.

Riché FC, Cholley BP, Laisné MJ, Vicaut E, Panis YH, Lajeunie EJ, Boudiaf M, Valleur PD.

Surgery. 2003 Mar;133(3):257-62.

PMID:
12660636
6.

Plasma procalcitonin in patients with ileus. Relations to other inflammatory parameters.

Maruna P, Frasko R, Gürlich R.

Physiol Res. 2008;57(3):481-6. Epub 2007 May 30.

7.

Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease.

Adam B, Calikoglu E.

J Eur Acad Dermatol Venereol. 2004 May;18(3):318-20.

PMID:
15096143
8.

Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro.

Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, Limburg PC, ten Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH.

Crit Care Med. 2000 Feb;28(2):458-61.

PMID:
10708183
9.

Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.

Kocabaş E, Sarikçioğlu A, Aksaray N, Seydaoğlu G, Seyhun Y, Yaman A.

Turk J Pediatr. 2007 Jan-Mar;49(1):7-20.

10.

Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation.

Palombo JD, Burke PA, Moldawer LL, Forse RA, Lewis WD, Jenkins RL.

J Am Coll Surg. 1994 Aug;179(2):209-19.

PMID:
7519108
11.

Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation.

Potapov EV, Wagner FD, Loebe M, Ivanitskaia EA, Müller C, Sodian R, Jonitz B, Hetzer R.

Int J Cardiol. 2003 Dec;92(2-3):163-7.

PMID:
14659848
12.

The effect of Prometheus device on laboratory markers of inflammation and tissue regeneration in acute liver failure management.

Rocen M, Kieslichova E, Merta D, Uchytilova E, Pavlova Y, Cap J, Trunecka P.

Transplant Proc. 2010 Nov;42(9):3606-11. doi: 10.1016/j.transproceed.2010.07.103.

PMID:
21094824
13.

Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts.

Birks EJ, Burton PB, Owen V, Mullen AJ, Hunt D, Banner NR, Barton PJ, Yacoub MH.

Circulation. 2000 Nov 7;102(19 Suppl 3):III352-8.

14.

Donor cardiac troponin-I: a biochemical surrogate of heart function.

Venkateswaran RV, Ganesh JS, Thekkudan J, Steeds R, Wilson IC, Mascaro J, Thompson R, Bonser RS.

Eur J Cardiothorac Surg. 2009 Aug;36(2):286-92; discussion 292. doi: 10.1016/j.ejcts.2009.02.031. Epub 2009 Apr 25.

PMID:
19394856
15.

Early donor management increases the retrieval rate of lungs for transplantation.

Venkateswaran RV, Patchell VB, Wilson IC, Mascaro JG, Thompson RD, Quinn DW, Stockley RA, Coote JH, Bonser RS.

Ann Thorac Surg. 2008 Jan;85(1):278-86; discussion 286.

PMID:
18154823
16.

Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know?

Franke A, Lante W, Fackeldey V, Becker HP, Kurig E, Zöller LG, Weinhold C, Markewitz A.

Eur J Cardiothorac Surg. 2005 Oct;28(4):569-75.

PMID:
16135408
17.

Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis.

Oberhoffer M, Karzai W, Meier-Hellmann A, Bögel D, Fassbinder J, Reinhart K.

Crit Care Med. 1999 Sep;27(9):1814-8.

PMID:
10507603
18.

The value of serum procalcitonin in differential diagnosis of pulmonary embolism and community-acquired pneumonia.

Köktürk N, Kanbay A, Bukan N, Ekim N.

Clin Appl Thromb Hemost. 2011 Oct;17(5):519-25. doi: 10.1177/1076029610375425. Epub 2010 Aug 10.

PMID:
20699253
19.

[Tumor necrosis factor, interleukin-6, endotoxin and procalcitonin in septic shock in patients with hematologic neoplasms].

Galstian GM, Berkovskiĭ AL, Zueva VA, Kariakin AV, Levina AA, Sergeeva EV, Speranskaia LL, Gorodetskiĭ VM.

Ter Arkh. 2002;74(7):56-61. Russian.

PMID:
12181838
20.

The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.

Kolsum U, Roy K, Starkey C, Borrill Z, Truman N, Vestbo J, Singh D.

Int J Chron Obstruct Pulmon Dis. 2009;4:149-56. Epub 2009 Apr 15.

Items per page

Supplemental Content

Write to the Help Desk